On 21 September 2026, CDB LEASING (01606.HK) said the Shenzhen Financial Regulatory Bureau approved Bao Quanyong as its president and executive director.
On 21 September 2026, MOBI DEV (00947.HK) said its Ji'an subsidiary's cavity filter project won a second prize at the 2025 Jiangxi Science and Technology Award.
on September 21, 2026, the three major Hong Kong indices strengthened collectively, with the Hang Seng Index up 1.18%, the Hang Seng TECH Index up 0.40%, and the Hang Seng China Enterprises Index up 1.39%.
On 21 September 2026, QIDIAN GUOFENG (01280.HK) said a substantial shareholder pledged 277,047,032 shares to secure a HKD 50.8m loan repayable within a year.
MANYCORE TECH (00068.HK) fell 0.71% to HKD 8.425. It open-sourced UniPhysGen with Zhejiang University; a world model forum took place at Tsinghua University.
On 21 September, SMIC (00981.HK) quoted HKD 64.900, down 0.38%. UMC signalled price rises, PSMC up to 40%; South Korea 1-20 September chip exports rose 259%.
on 21 September 2026, humanoid robot stocks traded with volatility while UBTECH ROBOTICS (09880.HK) weakened. As of 13:10, the company quoted HKD 79.350, down 1.86%.SCS believes that humanoid robots have entered the order validation phase, with the industry's main theme shifting from single product launches to mass production validation and large-scale commercialisation.
On 21 September 2026, INSILICO (03696.HK) announced a collaboration worth up to tens of millions of US dollars with a frontier foundation model laboratory to jointly develop and commercialise biology foundation models.
On 21 September 2026, JSMART TECH (00567.HK) announced plans to expand into embodied AI and AI computing storage and signed a cooperation agreement with SVA Distribution to jointly develop robotics markets in Hong Kong, Macao and Asia-Pacific.
On 21 September 2026, CR HOLDINGS (01911.HK) announced that its wholly-owned subsidiary acted as sole financial adviser to help Beijing SiliconFlow Technology complete its Series B+ second tranche and Series C financings, with backers including national-level funds.
On 21 September 2026, GENFLEET-B (02595.HK) announced that it had repurchased 872,000 H shares on the Stock Exchange as at 18 September, representing about 0.227% of its total issued share capital as at the announcement date.
On 21 September 2026, ABBISKO-B (02256.HK) announced that lavengratinib, its FGFR2/3 inhibitor, showed positive interim Phase II results in paediatric achondroplasia, with AHV rising 2.4 cm/year from baseline and a 100% response rate at 27 weeks.
On 21 September 2026, VOBILE GROUP (03738.HK) announced the launch of its SeeBay™ one-stop platform on 17 September, with cumulative registered users exceeding 20,000 and more than 13,600 content creation tasks added as at the previous day.
On 21 September 2026, NEW WORLD DEV (00017.HK) announced that the SSE accepted its spin-off application on 19 September to list a publicly offered commercial real estate investment trust holding the K11 Shanghai property, with an expected offering size of about RMB 3,818 million.
On 21 September 2026, HANSOH PHARMA (03692.HK) announced that its self-developed TYK2 inhibitor HS-10374 met co-primary endpoints in a pivotal Phase III trial in moderate-to-severe plaque psoriasis, with PASI 75 and sPGA 0/1 rates significantly exceeding placebo at week 16.
On 21 September 2026, BRONCUS-B (02216.HK) announced that its wholly-owned subsidiary and Max Grand Limited terminated a share transfer agreement on 20 September, with a USD 5,512,019.2 deposit to be refunded within five business days.
